Similarly, another cohort study (n = 148) reported that 37.2% of the patients hospitalized with COVID‐19 have an abnormal liver function, indicated by elevated ALT, AST, g‐glutamyltransferase, alkaline phosphatase (ALP), and total bilirubin.91 The gene discussed is GPT; the disease is COVID-19.